Ann Pediatr Endocrinol Metab.  2015 Dec;20(4):220-225. 10.6065/apem.2015.20.4.220.

Cerebral salt-wasting syndrome after hematopoietic stem cell transplantation in adolescents: 3 case reports

Affiliations
  • 1Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea. suhbk@catholic.ac.kr

Abstract

Cerebral salt-wasting syndrome (CSWS) is a rare disease characterized by a extracellular volume depletion and hyponatremia induced by marked natriuresis. It is mainly reported in patients who experience a central nervous system insult, such as cerebral hemorrhage or encephalitis. The syndrome of inappropriate antidiuretic hormone secretion is a main cause of severe hyponatremia after hematopoietic stem cell transplantation, whereas CSWS is rarely reported. We report 3 patients with childhood acute leukemia who developed CSWS with central nervous system complication after hematopoietic stem cell transplantation. The diagnosis of CSW was made on the basis of severe hyponatremia accompanied by increased urine output with clinical signs of dehydration. All patients showed elevated natriuretic peptide and normal antidiuretic hormone. Aggressive water and sodium replacement treatment was instituted in all 3 patients and 2 of them were effectively recovered, the other one was required to add fludrocortisone administration.

Keyword

Hyponatremia; Sodium; Polyuria; Hematopoietic stem cell transplantation

MeSH Terms

Central Nervous System
Cerebral Hemorrhage
Dehydration
Diagnosis
Encephalitis
Fludrocortisone
Hematopoietic Stem Cell Transplantation*
Hematopoietic Stem Cells*
Humans
Hyponatremia
Leukemia
Natriuresis
Polyuria
Rare Diseases
Sodium
Water
Fludrocortisone
Sodium
Water

Figure

  • Fig. 1 (A) Diffuse fluid-attenuated inversion recovery image high SI lesions in both periventicular white matter, probably chemotherapy-induced leukoencephalopathy on posttransplant day 64 in case 2. (B) Diffusion magnetic resonance imaging show prominent pachymeningeal enhancement on posttransplant day 21 in case 3.


Reference

1. Rubin J, Wide K, Remberger M, Gustafsson B. Acute neurological complications after hematopoietic stem cell transplantation in children. Pediatr Transplant. 2005; 9:62–67. PMID: 15667614.
Article
2. Tabbara IA, Zimmerman K, Morgan C, Nahleh Z. Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med. 2002; 162:1558–1566. PMID: 12123398.
3. Barba P, Pinana JL, Valcarcel D, Querol L, Martino R, Sureda A, et al. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2009; 15:1439–1446. PMID: 19822304.
Article
4. Papadimitriou DT, Spiteri A, Pagnier A, Bayle M, Mischalowski MB, Bourdat G, et al. Mineralocorticoid deficiency in post-operative cerebral salt wasting. J Pediatr Endocrinol Metab. 2007; 20:1145–1150. PMID: 18051934.
Article
5. Lim YJ, Park EK, Koh HC, Lee YH. Syndrome of inappropriate secretion of antidiuretic hormone as a leading cause of hyponatremia in children who underwent chemotherapy or stem cell transplantation. Pediatr Blood Cancer. 2010; 54:734–737. PMID: 20205255.
Article
6. Cerdà-Esteve M, Cuadrado-Godia E, Chillaron JJ, Pont-Sunyer C, Cucurella G, Fernandez M, et al. Cerebral salt wasting syndrome: review. Eur J Intern Med. 2008; 19:249–254. PMID: 18471672.
Article
7. Momi J, Tang CM, Abcar AC, Kujubu DA, Sim JJ. Hyponatremia-what is cerebral salt wasting? Perm J. 2010; 14:62–65. PMID: 20740122.
Article
8. Yee AH, Burns JD, Wijdicks EF. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg Clin N Am. 2010; 21:339–352. PMID: 20380974.
Article
9. Saleh M. Sepsis-associated renal salt wasting: how much is too much? BMJ Case Rep. 2014; 1. 9. [Epub]. DOI: 10.1136/bcr-2013-201838.
Article
10. Najima Y, Ohashi K, Ando M, Koshida A, Yamashita T, Akiyama H, et al. Salt-wasting nephropathy induced by foscarnet treatment for HHV-6 encephalitis in a hematopoietic stem cell transplant. Rinsho Ketsueki. 2008; 49:40–45. PMID: 18277595.
11. Yuda S, Mori T, Kato J, Koda Y, Kohashi S, Kikuchi T, et al. Sodium-losing nephropathy caused by tacrolimus after allogeneic hematopoietic stem cell transplantation. Rinsho Ketsueki. 2013; 54:2187–2191. PMID: 24452151.
12. Weber C, Schaper J, Tibussek D, Adams O, Mackenzie CR, Dilloo D, et al. Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantation. Bone Marrow Transplant. 2008; 41:253–259. PMID: 17982498.
Article
13. Siegal D, Keller A, Xu W, Bhuta S, Kim DH, Kuruvilla J, et al. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant. 2007; 13:1369–1379. PMID: 17950923.
Article
14. Azik F, Yazal Erdem A, Tavil B, Bayram C, Tunc B, Uckan D. Neurological complications after allogeneic hematopoietic stem cell transplantation in children, a single center experience. Pediatr Transplant. 2014; 18:405–411. PMID: 24802348.
Article
15. Oh JY, Shin JI. Syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome: similarities and differences. Front Pediatr. 2015; 2:146. PMID: 25657991.
Article
16. Kirchhoff C, Stegmaier J, Bogner V, Buhmann S, Mussack T, Kreimeier U, et al. Intrathecal and systemic concentration of NT-proBNP in patients with severe traumatic brain injury. J Neurotrauma. 2006; 23:943–949. PMID: 16774478.
Article
17. Rabinstein AA, Wijdicks EF. Hyponatremia in critically ill neurological patients. Neurologist. 2003; 9:290–300. PMID: 14629783.
Article
18. Kawaguchi T, Takeuchi M, Kawajiri C, Abe D, Nagao Y, Yamazaki A, et al. Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation. Transpl Infect Dis. 2013; 15:E54–E57. PMID: 23173742.
Article
19. Berger AK, Bellos F, Siegmund A, Eisenbach C, Lordick F. Symptomatic hyponatraemia caused by cylophosphamide. Onkologie. 2009; 32:280–282. PMID: 19420976.
Article
20. Taplin CE, Cowell CT, Silink M, Ambler GR. Fludrocortisone therapy in cerebral salt wasting. Pediatrics. 2006; 118:e1904–e1908. PMID: 17101713.
Article
Full Text Links
  • APEM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr